Literature DB >> 23065234

Association of RANTES and MBL gene polymorphisms with systemic lupus erythematosus: a meta-analysis.

Wang-Dong Xu1, Hui Peng, Mo Zhou, Min Zhang, Bao-Zhu Li, Hai-Feng Pan, Dong-Qing Ye.   

Abstract

The RANTES (regulated on activation normal T cell expressed and secreted) and MBL (mannose binding lectin) single-nucleotide polymorphisms have been repeatedly associated with systemic lupus erythematosus (SLE), but the findings are not consistent across studies. The aim of this study was to determine whether the functional RANTES-28, -403 and MBL2 A/O polymorphisms confer susceptibility to SLE in multiple ethnic populations. A meta-analysis was conducted (allelic contrast, the additive model, the dominant model and the recessive model) on RANTES with seven studies (four studies for RANTES-28: three Asian and one American studies; three studies for RANTES-403: two Asian and one European studies), MBL with eight studies (five European and three American studies). OR is used as a measure of the effect of the association in a fixed/random effects model. The meta-analysis indicated that none of the two polymorphisms in gene of the RANTES showed any significant association with SLE risk, respectively, except for the recessive model (OR = 1.24, 95 % CI: 1.01-1.52, P = 0.04) in all study subjects combined with the two polymorphisms. According to the MBL2 A/O polymorphism, the results indicated a significant association between the polymorphism and SLE in allelic contrast (OR = 0.83, 95 % CI: 0.73-0.93, P = 0.002). While stratified by ethnicity in European, no significant association was found. In summary, the present study suggests that the RANTES-28, -403 polymorphisms do not associate with SLE, but the MBL2 A/O polymorphism might associate with SLE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23065234     DOI: 10.1007/s11033-012-2135-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  33 in total

1.  Lack of association of interleukin-18 gene promoter -607 A/C polymorphism with susceptibility to autoimmune diseases: a meta-analysis.

Authors:  H-F Pan; R-X Leng; D-Q Ye
Journal:  Lupus       Date:  2011-06-02       Impact factor: 2.911

2.  Messenger RNA expression of RANTES in the urinary sediment of patients with lupus nephritis.

Authors:  Rebecca Wing-Yan Chan; Fernand Mac-Moune Lai; Edmund Kwok-Ming Li; Lai-Shan Tam; Kai-Ming Chow; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Nephrology (Carlton)       Date:  2006-06       Impact factor: 2.506

3.  Urinary levels of RANTES and M-CSF are predictors of lupus nephritis flare.

Authors:  S Tian; J Li; L Wang; T Liu; H Liu; G Cheng; D Liu; Y Deng; R Gou; Y Wan; J Jia; C Chen
Journal:  Inflamm Res       Date:  2007-07       Impact factor: 4.575

4.  RANTES gene polymorphisms and asthma risk: A meta-analysis.

Authors:  Yong-Gang Zhang; Jin Huang; Jie Zhang; Xiao-Bo Li; Chao He; Yu-Ling Xiao; Can Tian; Hua Wan; Yu-Liang Zhao; Yangzom-Ghising Tsewang; Hong Fan
Journal:  Arch Med Res       Date:  2010-01       Impact factor: 2.235

5.  Circulating levels of beta-chemokines in systemic lupus erythematosus.

Authors:  H Kaneko; H Ogasawara; T Naito; H Akimoto; S Lee; T Hishikawa; I Sekigawa; Y Tokano; Y Takasaki; S I Hirose; H Hashimoto
Journal:  J Rheumatol       Date:  1999-03       Impact factor: 4.666

6.  Association of mannose-binding lectin gene variation with disease severity and infections in a population-based cohort of systemic lupus erythematosus patients.

Authors:  P Garred; A Voss; H O Madsen; P Junker
Journal:  Genes Immun       Date:  2001-12       Impact factor: 2.676

7.  TLR9 polymorphisms and systemic lupus erythematosus risk in Asians: a meta-analysis study.

Authors:  Zaixing Yang; Yan Liang; Baodong Qin; Chang Li; Renqian Zhong
Journal:  Cytokine       Date:  2011-12-16       Impact factor: 3.861

8.  Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus.

Authors:  C Eriksson; K Eneslätt; J Ivanoff; S Rantapää-Dahlqvist; K G Sundqvist
Journal:  Lupus       Date:  2003       Impact factor: 2.911

9.  Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX.

Authors:  Geoffrey Hom; Robert R Graham; Barmak Modrek; Kimberly E Taylor; Ward Ortmann; Sophie Garnier; Annette T Lee; Sharon A Chung; Ricardo C Ferreira; P V Krishna Pant; Dennis G Ballinger; Roman Kosoy; F Yesim Demirci; M Ilyas Kamboh; Amy H Kao; Chao Tian; Iva Gunnarsson; Anders A Bengtsson; Solbritt Rantapää-Dahlqvist; Michelle Petri; Susan Manzi; Michael F Seldin; Lars Rönnblom; Ann-Christine Syvänen; Lindsey A Criswell; Peter K Gregersen; Timothy W Behrens
Journal:  N Engl J Med       Date:  2008-01-20       Impact factor: 91.245

Review 10.  Mannose-binding lectin deficiency--revisited.

Authors:  Peter Garred; Flemming Larsen; Hans O Madsen; Claus Koch
Journal:  Mol Immunol       Date:  2003-09       Impact factor: 4.407

View more
  5 in total

1.  Mannose-binding lectin (MBL) codon 54 (rs1800450) polymorphism predisposes towards medium vessel vasculitis in patients with systemic lupus erythematosus.

Authors:  Vir Singh Negi; Panneer Devaraju; Durga Prasanna Misra; Vikramraj K Jain; Jignesh Babulal Usdadiya; Paul T Antony; Reena Gulati
Journal:  Clin Rheumatol       Date:  2017-01-17       Impact factor: 2.980

2.  A study on the association of autoantibodies, chemokine, and its receptor with disease activity in systemic lupus erythematosus in North Indian population.

Authors:  Leishangthem Bidyalaxmi Devi; Archana Bhatnagar; Ajay Wanchu; Aman Sharma
Journal:  Rheumatol Int       Date:  2013-07-06       Impact factor: 2.631

3.  Mannose binding lectin (MBL) 2 gene polymorphism & its association with clinical manifestations in systemic lupus erythematosus (SLE) patients from western India.

Authors:  Vandana Pradhan; Prathamesh Surve; Anjali Rajadhyaksha; Vinod Rajendran; Manisha Patwardhan; Vinod Umare; Kanjaksha Ghosh; Anita Nadkarni
Journal:  Indian J Med Res       Date:  2015-02       Impact factor: 2.375

Review 4.  Complement as a Therapeutic Target in Systemic Autoimmune Diseases.

Authors:  María Galindo-Izquierdo; José Luis Pablos Alvarez
Journal:  Cells       Date:  2021-01-13       Impact factor: 6.600

5.  Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet's disease: an updated meta-analysis.

Authors:  Min Zhang; Wang-Dong Xu; Peng-Fei Wen; Yan Liang; Jie Liu; Hai-Feng Pan; Dong-Qing Ye
Journal:  Mol Vis       Date:  2013-09-12       Impact factor: 2.367

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.